Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Azelastine
Cat. No.:
OB0225LY-0157
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
Azelastine is an antihistamine with rapid allergy symptom relief.
Synonym:
Azelastina; Astelin; Azelastinum; 58581-89-8; 4-(4-Chlorobenzyl)-2-(1-methylazepan-4-yl)phthalazin-1(2H)-one; 4-[(4-Chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one; 4-(p-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone; 1(2H)-Phthalazinone,4-[(4-chlorophenyl)methyl]-2-[(4S)-hexahydro-1-methyl-H-azepin-4-yl]-
CAS No.:
58581-89-8
Compound CID:
2267
Formula:
C22H24ClN3O
Formula Weight:
381.9
Specification
Relative Density:
1.25 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Azelastine can be used in the study of respiratory allergic reactions or play an important role in the development of new allergy drugs.
Library Information
Targets:
Histamine receptor; SARS-CoV
Receptors:
H1 receptor
Pathways:
Microbiology/Virology; GPCR/G protein; Immunology/Inflammation; Neuronal signaling
Plate Number:
AOCL-2
Plate Location:
h10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
3.82 mg/mL; 10 mM
